248 related articles for article (PubMed ID: 18296003)
21. Microbiological investigation of a hospital outbreak of invasive group A streptococcal disease in Krakow, Poland.
Strus M; Drzewiecki A; Chmielarczyk A; Tomusiak A; Romanek P; Kosowski K; Kochan P; van der Linden M; Lütticken R; Heczko PB
Clin Microbiol Infect; 2010 Sep; 16(9):1442-7. PubMed ID: 20041902
[TBL] [Abstract][Full Text] [Related]
22. Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the United States.
Shulman ST; Stollerman G; Beall B; Dale JB; Tanz RR
Clin Infect Dis; 2006 Feb; 42(4):441-7. PubMed ID: 16421785
[TBL] [Abstract][Full Text] [Related]
23. Molecular epidemiology of group A streptococcus causing scarlet fever in northern Taiwan, 2001-2002.
Chen YY; Huang CT; Yao SM; Chang YC; Shen PW; Chou CY; Li SY
Diagn Microbiol Infect Dis; 2007 Jul; 58(3):289-95. PubMed ID: 17532590
[TBL] [Abstract][Full Text] [Related]
24. The genetic properties of Streptococcus pyogenes emm49 genotype strains recently emerged among severe invasive infections in Japan.
Ikebe T; Endo M; Ueda Y; Okada K; Suzuki R; Minami T; Tanaka H; Nakanishi N; Tomita M; Nishie H; Ishii N; Sasaki E; Miura Y; Yamamura T; Watanabe H
Jpn J Infect Dis; 2004 Aug; 57(4):187-8. PubMed ID: 15329456
[No Abstract] [Full Text] [Related]
25. The innate immune response elicited by Group A Streptococcus is highly variable among clinical isolates and correlates with the emm type.
Dinis M; Plainvert C; Kovarik P; Longo M; Fouet A; Poyart C
PLoS One; 2014; 9(7):e101464. PubMed ID: 24991887
[TBL] [Abstract][Full Text] [Related]
26. Systemic cytokine response in moribund mice of streptococcal toxic shock syndrome model.
Saito M; Kajiwara H; Iida K; Hoshina T; Kusuhara K; Hara T; Yoshida S
Microb Pathog; 2011 Feb; 50(2):109-13. PubMed ID: 21146602
[TBL] [Abstract][Full Text] [Related]
27. Decrease of erythromycin resistance in group A streptococci by change of emm distribution.
Koh EH; Kim S; Lee NY
Jpn J Infect Dis; 2008 Jul; 61(4):261-3. PubMed ID: 18653965
[TBL] [Abstract][Full Text] [Related]
28. Group A streptococcal pharyngitis serotype surveillance in North America, 2000-2002.
Shulman ST; Tanz RR; Kabat W; Kabat K; Cederlund E; Patel D; Li Z; Sakota V; Dale JB; Beall B;
Clin Infect Dis; 2004 Aug; 39(3):325-32. PubMed ID: 15306998
[TBL] [Abstract][Full Text] [Related]
29. Comparison of emm typing and ribotyping with three restriction enzymes to characterize clinical isolates of Streptococcus pyogenes.
Doktor SZ; Beyer JM; Flamm RK; Shortridge VD
J Clin Microbiol; 2005 Jan; 43(1):150-5. PubMed ID: 15634964
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of emm types 1 and 12 from invasive Streptococcus pyogenes disease in Greece--results of enhanced surveillance.
Stathi A; Papaparaskevas J; Zachariadou L; Pangalis A; Legakis NJ; Tseleni-Kotsovili A; ; Tassios PT
Clin Microbiol Infect; 2008 Aug; 14(8):808-12. PubMed ID: 18727807
[TBL] [Abstract][Full Text] [Related]
31. [Multifocal inflammatory syndrome after invasive infection due to an M1 strain of Streptococcus pyogenes].
Filleron A; Marchandin H; Rodière M; Jeziorski E
Arch Pediatr; 2010 Sep; 17(9):1300-3. PubMed ID: 20709506
[TBL] [Abstract][Full Text] [Related]
32. Molecular genetic analysis of 675 group A streptococcus isolates collected in a carrier study at Lackland Air Force Base, San Antonio, Texas.
Hoe NP; Fullerton KE; Liu M; Peters JE; Gackstetter GD; Adams GJ; Musser JM
J Infect Dis; 2003 Sep; 188(6):818-27. PubMed ID: 12964112
[TBL] [Abstract][Full Text] [Related]
33. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
[TBL] [Abstract][Full Text] [Related]
34. Peripheral blood mononuclear cells proliferation and Th1/Th2 cytokine production in response to streptococcal M protein in psoriatic patients.
Pérez-Lorenzo R; Núñez-Oreza LA; Garma-Quen PM; López-Pacheco E; Bricaire-Bricaire G
Int J Dermatol; 2006 May; 45(5):547-53. PubMed ID: 16700789
[TBL] [Abstract][Full Text] [Related]
35. Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden.
Darenberg J; Luca-Harari B; Jasir A; Sandgren A; Pettersson H; Schalén C; Norgren M; Romanus V; Norrby-Teglund A; Normark BH
Clin Infect Dis; 2007 Aug; 45(4):450-8. PubMed ID: 17638193
[TBL] [Abstract][Full Text] [Related]
36. Innate immune response to intramammary infection with Serratia marcescens and Streptococcus uberis.
Bannerman DD; Paape MJ; Goff JP; Kimura K; Lippolis JD; Hope JC
Vet Res; 2004; 35(6):681-700. PubMed ID: 15535958
[TBL] [Abstract][Full Text] [Related]
37. Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population.
Yoonim N; Olive C; Pruksachatkunakorn C; Pruksakorn S
BMC Microbiol; 2006 Aug; 6():71. PubMed ID: 16895610
[TBL] [Abstract][Full Text] [Related]
38. Emerging fluoroquinolone-non-susceptible group A streptococci in two different paediatric populations.
Smeesters PR; Vergison A; Junior DC; Van Melderen L
Int J Antimicrob Agents; 2009 Jul; 34(1):44-9. PubMed ID: 19269141
[TBL] [Abstract][Full Text] [Related]
39. Synergic activities of streptococcal pyrogenic exotoxin A and lipoteichoic acid in cytokine induction.
Cusumano V; Fera MT; Carbone M; Anzani Ciliberti F; Bellantoni A; Cusumano V
New Microbiol; 2000 Jan; 23(1):37-45. PubMed ID: 10946404
[TBL] [Abstract][Full Text] [Related]
40. Resistance to bacitracin in Streptococcus pyogenes from oropharyngeal colonization and noninvasive infections in Portugal was caused by two clones of distinct virulence genotypes.
Pires R; Rolo D; Mato R; Feio de Almeida J; Johansson C; Henriques-Normark B; Morais A; Brito-Avô A; Gonçalo-Marques J; Santos-Sanches I
FEMS Microbiol Lett; 2009 Jun; 296(2):235-40. PubMed ID: 19486163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
